Faculty profile

Brian Feagan

Director, Robarts Clinical Trials Inc., Cross-Appointed ProfessorDepartment of Epidemiology and BiostatisticsWestern University

Brian Feagan

Director, Robarts Clinical Trials Inc., Cross-Appointed Professor

Department of Epidemiology and Biostatistics

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
12 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

611

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Latest papers

Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.
The lancet. Gastroenterology & hepatology · 2026
Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.
Radiographics : a review publication of the Radiological Society of North America, Inc · 2025

All 34 publications

Latest funding

Nomination to the 2013 Knowledge Translation Prize for Cochrane Canada
CIHR · 2013 · Co-investigator
$100,000
Dr Cochrane: developing online learning modules from Cochrane reviews
CIHR · 2011 · Co-investigator
$100,000
Oral Methotrexate for Active Crohn's Disease
CIHR · 2010 · Nominated PI
$1,019,498

All 6 grants and awards

34 publications.

Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review.

Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu MT, Atreya R, Al-Bawardy B, Connor SJ, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin DT, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2026

DOI: 10.1016/j.cgh.2025.03.024 PMID: 40378982

Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.

Cohen NA, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu MT, Atreya R, Al-Bawardy B, Connor SJ, D'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin CRH, Hernandez-Rocha C, Kobayashi T, Leibovitzh H, Lu C, Maharshak N, Naseer M, Ollech J, Rubin DT, Sebastian S, Siegmund B, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Aswani Omprakash T, Frenkel L, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F, Study of Upper Gastrointestinal Manifestations and Management of Crohn's Disease (SUMM-CD) Group

The lancet. Gastroenterology & hepatology2026

DOI: 10.1016/s2468-1253(25)00347-4 PMID: 41520669

Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.

Hoodeshenas S, Dillman JR, Taylor SA, Rimola J, Taouli B, Robinson KA, Lu A, Bartlett DJ, Bruining DH, Hagen CE, Goenka AH, Chen S, Rieder F, Feagan B, Baker ME, Fletcher JG

Radiographics : a review publication of the Radiological Society of North America, Inc2025

DOI: 10.1148/rg.240226 PMID: 41100354

A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis.

Danese S, Rothenberg ME, Lim JJ, Ding HT, McBride JM, Chen Y, Dash A, Mar JS, Keir M, Peyrin-Biroulet L, Panes J, Colombel JF, Feagan B, Valentine JF, Schreiber S

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2025

DOI: 10.1016/j.cgh.2024.11.013 PMID: 39694207

Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial.

Silveira CRA, Coleman KKL, Borron K, Tirona RG, Rupar CA, Zou G, Hegele RA, Wellington C, Stukas S, Finger EC, Bartha R, Morrow SA, Wells JL, Borrie MJ, Mahuran D, MacDonald PA, Jenkins ME, Jog MS, Dresser G, Fox S, Camicioli R, Feagan B, Mendonça DA, Mayich M, Sharma MD, Pandey SK, Pasternak SH

JAMA neurology2025

DOI: 10.1001/jamaneurol.2025.1687 PMID: 40587145

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies.

Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, Hisamatsu T, Siegmund B, Kligys K, Song A, Zambrano J, Mallick M, Zhang Y, Armuzzi A, D'Haens G

Journal of Crohn's & colitis2025

DOI: 10.1093/ecco-jcc/jjae164 PMID: 39485390

Diagnosis and Management of Inflammatory Bowel Disease-Associated Spondyloarthritis.

Falloon K, Forney M, Husni ME, Feagan B, Rieder F

The American journal of gastroenterology2025

DOI: 10.14309/ajg.0000000000003092 PMID: 39360937

Lymphocyte Trafficking in Inflammatory Bowel Disease.

Feagan B

Gastroenterology & hepatology2024First author

PMID: 39193075

Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review.

Silverman AL, Bouchiba H, Aelvoet A, MacDonald J, Dekker E, Zayadi A, Le J, Feagan B, Jairath V, Ma C, Samadder J

Endoscopy international open2024

DOI: 10.1055/a-2330-8037 PMID: 38904059

Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.

Ferrante M, Irving PM, Abreu MT, Axler J, Gao X, Cao Q, Fujii T, Rausch A, Torres J, Neimark E, Song A, Wallace K, Kligys K, Berg S, Liao X, Zhou Q, Kalabic J, Feagan B, Panaccione R

Journal of Crohn's & colitis2024

DOI: 10.1093/ecco-jcc/jjad168 PMID: 37797293

Nomination to the 2013 Knowledge Translation Prize for Cochrane Canada

Co-investigatorCIHR2013Knowledge Translation Prize

Principal investigators: Grimshaw, Jeremy M

Keywords: Knowledge Translation

$100,000

Dr Cochrane: developing online learning modules from Cochrane reviews

Co-investigatorCIHR2011Knowledge Translation Supplement

Principal investigators: Grimshaw, Jeremy M

Keywords: Cochrane Collaboration; Continuing Education And Professional Development; On-Line Learning Resources

$100,000

Oral Methotrexate for Active Crohn's Disease

Nominated PICIHR2010Operating Grant

Principal investigators: Feagan, Brian G

Keywords: Crohn'S Disease; Methotrexate; Pharmacogenomics; Pharmacokinetics; Placebo-Controlled; Randomized

$1,019,498

Knowledge Synthesis and Translation by Cochrane Canada

Principal investigatorCIHR2009Canadian Cochrane Network and Centre (CCNC)

Principal investigators: Grimshaw, Jeremy M; Beyene, Joseph; Bombardier, Claire; Feagan, Brian G; Klassen, Terry P; Lavis, John N; Moayyedi, Paul; Moher, David; Tugwell, Peter S; Wright, James M

Keywords: Back Conditions; Bowel Disease And Disorders; Effective Practice; Gastrointestinal Disease And Disorders; Hypertension; Knowledge Translation; Meta-Analysis; Musculoskeletal Disorders; Organization Of Care; Pancreatic Disease And Disorders; Systematic Reviews

$9,591,936

Effect of lowering the dialysate sodium on ambulatory blood pressure in hemodialysis patients: A randomized controlled trial

Co-investigatorCIHR2009Randomized Controlled Trials

Principal investigators: Suri, Rita

Keywords: Blood Pressure; Dialysate Composition; Hemodialysis; Interdialystic Weight Gain; Sodium; Thirst

$171,891

Oral Methotrexate for Active Crohn's Disease

Nominated PICIHR2009Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding

Principal investigators: Feagan, Brian G

Keywords: Crohn'S Disease; Methotrexate; Pharmacogenomics; Pharmacokinetics; Placebo-Controlled; Randomized

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Brian Feagan

Research

Latest papers

Latest funding

Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review.

Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.

Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.

A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis.

Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial.

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies.

Diagnosis and Management of Inflammatory Bowel Disease-Associated Spondyloarthritis.

Lymphocyte Trafficking in Inflammatory Bowel Disease.

Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review.

Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.

Nomination to the 2013 Knowledge Translation Prize for Cochrane Canada

Dr Cochrane: developing online learning modules from Cochrane reviews

Oral Methotrexate for Active Crohn's Disease

Knowledge Synthesis and Translation by Cochrane Canada

Effect of lowering the dialysate sodium on ambulatory blood pressure in hemodialysis patients: A randomized controlled trial

Oral Methotrexate for Active Crohn's Disease

Frequent collaborators

Remo Panaccione

Cathy Lu

John Kenneth Marshall

Christopher Ma

Vipul Jairath

Aaron Haig

Jennifer Jones

Anne Griffiths

Robert Bartha

Kenneth Croitoru

Anthony Otley

David Mack

Alain Bitton

Wei Xu

Susan Fox

Guangyong Zou

Paul Moayyedi

Osvaldo Espin Garcia

Michael Surette

Grigorios Leontiadis

Frances Tse